topiramate and Fever-of-Unknown-Origin

topiramate has been researched along with Fever-of-Unknown-Origin* in 1 studies

Other Studies

1 other study(ies) available for topiramate and Fever-of-Unknown-Origin

Article	Year
[One-night psychotic episode during topiramate treatment in connection with an acute febrile infection]. Neuropsychiatrie : Klinik, Diagnostik, Therapie und Rehabilitation : Organ der Gesellschaft Osterreichischer Nervenarzte und Psychiater, 2007, Volume: 21, Issue:1 Topiramate is an anticonvulsant which has been used more and more in recent years in psychiatry as well. The undesirable effects that have been observed remain relatively mild under conditions of slow titration. Psychotic symptoms have been described in connection with the use of topiramate in individual cases, however. It is not known which concomitant circumstances favour the appearance of this side-effect, though. This is a report about a psychotic attack that happened for the first time and lasted for one night in a borderline patient who was treated with topiramate 250 mg/day shortly after the start of a febrile infection. After the infection had gone, topiramate was given again and titrated to 300 mg/day. No further psychotic symptoms were observed. Topics: Adult; Anticonvulsants; Borderline Personality Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Fever of Unknown Origin; Fructose; Hallucinations; Humans; Male; Psychoses, Substance-Induced; Respiratory Tract Infections; Topiramate	2007

Article

Year

[One-night psychotic episode during topiramate treatment in connection with an acute febrile infection].

Neuropsychiatrie : Klinik, Diagnostik, Therapie und Rehabilitation : Organ der Gesellschaft Osterreichischer Nervenarzte und Psychiater, 2007, Volume: 21, Issue:1

Topiramate is an anticonvulsant which has been used more and more in recent years in psychiatry as well. The undesirable effects that have been observed remain relatively mild under conditions of slow titration. Psychotic symptoms have been described in connection with the use of topiramate in individual cases, however. It is not known which concomitant circumstances favour the appearance of this side-effect, though. This is a report about a psychotic attack that happened for the first time and lasted for one night in a borderline patient who was treated with topiramate 250 mg/day shortly after the start of a febrile infection. After the infection had gone, topiramate was given again and titrated to 300 mg/day. No further psychotic symptoms were observed.

Topics: Adult; Anticonvulsants; Borderline Personality Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Fever of Unknown Origin; Fructose; Hallucinations; Humans; Male; Psychoses, Substance-Induced; Respiratory Tract Infections; Topiramate

2007